Patent details

LUC00188 Product Name: acétate d’indacatérol ou xinafoate d’indacatérol, de préférence acétate d’indacatérol, en combinaison avec le furoate de mométasone et le glycopyrronium

Basic Information

Publication number:
LUC00188
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP078198991
Legal Status:
Inactive
Application number:
LUC00188
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
EU/1/20/1438
Marketing Authorization Type:
Marketing Authorization Date:
06/07/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
EU/1/20/1440
Marketing Authorization Type:
Marketing Authorization Date:
06/07/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
07/12/2020
First Marketing Authorization date:
06/07/2020
Grant date:
01/07/2024
Activation date:
Publication date:
07/12/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
02/07/2032
SPC Extension Expiration:
02/07/2032
Rejection date:
Withdrawal date:

Owner

From:
07/12/2020
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
07/12/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/01
Publication date:
05/01/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2024/10
Publication date:
06/08/2024
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
02/08/2027
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
07/12/2020 MA publication 10
07/12/2020 Application Form 4
07/12/2020 Marketing authorization 3
07/12/2020 Marketing authorization 3
07/12/2020 Outgoing Correspondence 1
07/12/2020 Summary of the product caracteristics 53
07/12/2020 General Document 1
07/12/2020 General Document 1
07/12/2020 Incoming Correspondence (Post) 3
07/12/2020 Summary of the product caracteristics 54
07/12/2020 Publication 1
01/07/2024 Publication 1
01/07/2024 Certificate 1
08/07/2024 Outgoing Correspondence 1